Showing results (131-140 of 153) with videos related to
Sort By:
Pageof 16
Stem Cell Research & Therapy|December 2, 2025
Efficacy and safety of autologous adipose-derived stem cells in subjects with moderate to severe atopic dermatitis: a multicenter, randomized, single-blind, placebo-controlled, phase 2 trialJoon Seok, Su-Young Kim, Woo Geon Lee, et al.The Journal of Dermatology|July 19, 2018
Survey of disease awareness, treatment behavior and treatment satisfaction in patients with atopic dermatitis in Korea: A multicenter studyHye Jung Jung, Joo Youn Bae, Jung Eun Kim, et al.Aesthetic Surgery Journal|July 4, 2026
A Randomized, Double-blind, Placebo-controlled, Dose Ranging, Parallel, Multi-Centre, Phase II Study to Evaluate the Efficacy and Safety of MT921 in Subjects with Moderate to Severe Submental FatSi-Hyung Lee, Woo Shun Lee, Min Kyung Shin, et al.Molecular Cancer Research : MCR|October 18, 2012
STAT3-RANTES autocrine signaling is essential for tamoxifen resistance in human breast cancer cellsEun Hee Yi, Chang Seok Lee, Jin-Ku Lee, et al.Annals of Dermatology|February 7, 2023
Effect of COVID-19 (SARS-CoV-2) Vaccination on Patients with Atopic Dermatitis Treated with Dupilumab: A Multicenter, Observational StudyTae Young Han, Dong Hyun Shim, Yu Jin Lee, et al.JMIR Public Health and Surveillance|March 10, 2025
Nationwide Trends in Screen Time and Associated Risk Factors by Family Structures Among Adolescents, 2008-2022: Nationwide Cross-Sectional StudySeokjun Kim, Hyesu Jo, Yejun Son, et al.Arthritis & Rheumatology (Hoboken, N.J.)|November 26, 2019
Negative Regulation of Osteoclast Commitment by Intracellular Protein Phosphatase Magnesium-Dependent 1AOh Chan Kwon, Bongkun Choi, Eun-Jin Lee, et al.Annals of Dermatology|April 29, 2021
Perceptions and Behavior Regarding Skin Health and Skin Care Products: Analysis of the Questionnaires for the Visitors of Skin Health Expo 2018Young Bok Lee, Min Kyung Shin, Joung Soo Kim, et al.The Journal of Dermatological Treatment|May 19, 2020
Efficacy and safety of guselkumab compared with placebo and adalimumab in Korean patients with moderate-to-severe psoriasis: post-hoc analysis from the phase III, double-blind, placebo- and active-comparator-controlled VOYAGE 1/2 trialsSang Woong Youn, Dae Young Yu, Tae Yoon Kim, et al.Journal of Toxicology and Environmental Health. Part A|October 25, 2014
Risk assessment of volatile organic compounds benzene, toluene, ethylbenzene, and xylene (BTEX) in consumer productsSeong Kwang Lim, Han Seung Shin, Kyung Sil Yoon, et al.Pageof 16